Management of patients with non-small cell lung cancer and poor performance status.
- 1 January 2003
- journal article
- review article
- Published by Springer Nature in Current Treatment Options in Oncology
- Vol. 4 (1) , 55-59
- https://doi.org/10.1007/s11864-003-0031-x
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung CancerNew England Journal of Medicine, 2002
- Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2002
- Outcome of patients with a performance status of 2 in Eastern Cooperative Oncology Group Study E1594Cancer, 2001
- Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable): a systematic reviewThorax, 2001
- Randomized Phase III Trial of Paclitaxel Plus Carboplatin Versus Vinorelbine Plus Cisplatin in the Treatment of Patients With Advanced Non–Small-Cell Lung Cancer: A Southwest Oncology Group TrialJournal of Clinical Oncology, 2001
- Single-agent versus combination chemotherapy in advanced non-small cell lung cancer (NSCLC): A CALGB randomized trial of efficacy, quality of life, and cost-effectivenessEuropean Journal Of Cancer, 2001
- Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trialsBMJ, 1995
- Concurrent hyperfractionated irradiation and chemotherapy for unresectable nonsmall cell lung cancer. Results of radiation therapy oncology group 90-15Cancer, 1995
- Radical radiotherapy for early nonsmall cell lung cancerInternational Journal of Radiation Oncology*Biology*Physics, 1995
- Curative radiotherapy for technically operable stage I nonsmall cell lung cancerInternational Journal of Radiation Oncology*Biology*Physics, 1994